Mourad Labadi Portfolio
mourad2081@gmail.comWelcome to the Interactive Financial Model!
This is a dynamic tool for valuing pharmaceutical assets. You can adjust assumptions in the 'Scenario Modeling' tab and see the impact in real-time.
Explore My Portfolio
Visit mouradlabadi.com for more than 30 projects, including customized apps, business cases, data analysis, and complex financial models.
Total rNPV
$2.2 B
Mouradpharm rNPV
$533 M
Licensee rNPV
$1.7 B
Success Rate (PoS)
30.2%
Total Deal Value
$400 M
Peak Sales
$4.2 B
Total Sales
$40.7 B
Total Royalties
$7.0 B
Mouradpharm NPV
$1.7 B
Licensee NPV
$5.7 B
Total Patent Holder Deduction
$0 M
Peak Captured Patients
1,816,557
NOPAT Over Time
Risk-Adjusted Deal Value Split
Projected Sales & Royalties
rNPV Contribution
Waterfall chart showing the rNPV buildup.
Total Patient Funnel Over Time
Total addressable patient pool vs. captured patients globally.
Key Value Drivers (Undiscounted)
A comparison of the undiscounted commercial outcomes.